Upping its ante against its rivals in the medical and pharma sector, Walgreens has finally completed its acquisition of Rite Aid’s (RAD)
Categories
Other Industries
Aetna follows UnitedHealth in passing on rebates to customers
Drastic increase in drug prices has, over the years, become a topic of heated discussions, especially with price-cut on prescription drugs being
Takeda likely to make a move for Shire
Japanese pharma giant Takeda Pharmaceuticals is said to be planning to bid for London’s leading drug company Shire Pharmaceuticals (Nasdaq: SHPG). The
Tighten your ‘hold’ on First Solar
Off late, First Solar (FSLR) has been trading in red, but the stock has seen a staggering 153% growth in the past
Caterpillar might crawl out of metal tariff stomping
After coming out of 2017 as the second best performing Dow component, Caterpillar (CAT) had somewhat a troubled ride this year. There
Glaxo buys Novartis’ share of consumer healthcare joint venture
U.K.-based pharma giant GlaxoSmithKline (GSK), which holds about a two-thirds share in the Consumer Healthcare business JV with its partner Novartis (NVS),
Viagra variant might help Pfizer revenue stand up
All good things come to an end — and that includes Pfizer’s run with its blockbuster drug Viagra. The drugmaker’s little blue
Last shot for Remington as gunmaker files for bankruptcy protection
Remington filed for Chapter 11 bankruptcy protection after two centuries in the gun manufacturing business. The country’s oldest gun maker has been
Dominion Energy inches closer to $14.6 billion SCANA acquisition
Early this year Dominion Energy (D) went public with its intention to buy SCANA Corp (SCG) - the parent company of South
Steve Wynn exits paving way for Galaxy
Steve Wynn, the founder of Wynn Resorts (WYNN), bids adieu to the gambling company by selling his entire stake. This latest development
Citi shoots down gun-loving clients
Seldom do we see the business world reacting to social issues so overwhelmingly as it did after the Florida school shooting. The
Pfizer’s dilemma: To sell or not to sell
Pfizer (PFE) has been contemplating on selling its consumer healthcare division for some time, and it had found two bidders — British
Risk-meter: How companies are affected by Toys “R” Us store closures
While filing for Chapter 11 bankruptcy protection in September last year, Toys “R” Us had stated that it would continue running its
Think before swiping your credit card: Orbitz is latest victim of data breach
Quite often, the conveniences the digital world offers come with risks of their own, and people around the world are waking up
FedEx delivers beyond expectations
FedEx Corp. (FDX) posted third-quarter 2018 results that exceeded market expectations. The company’s revenue and EPS numbers were higher compared to analyst
Lockheed Martin strikes high with the F-35
Defense stocks have seen considerable growth since mid-last year, thanks to the brickbats being exchanged between President Donald Trump and the Supreme
Kroger’s Fred Meyer store ends assault rifle sales
It was only weeks ago that Kroger (KR) decided to raise the minimum age for purchasing guns and ammunition to 21 at
AbbVie’s elagolix meet phase III trial target
Among the pharma stocks, AbbVie (ABBV) is a company that has got an impressive reputation for growing demand for its drugs, new
Is it ‘game over’ for ExxonMobil?
Once the darling of the Oil & Gas industry, ExxonMobil (XOM), has now lost its sheen. Gone are those days when the
Soaring traffic: Airline industry glides to a shining future
If there is an industry that explicitly manifests the health of the economy, it would be civil aviation. The theory is rooted
Celgene – a sweet or sour pill?
It’s no big secret that investment in biotech stocks can offer great returns for investors, and at the same time do some